iTeos Therapeutics Files 8-K on Security Holder Vote Matters
| Field | Detail |
|---|---|
| Company | Iteos Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
Related Tickers: ITOS
TL;DR
iTeos Therapeutics (ITOS) is having a shareholder vote on June 17th - watch for updates.
AI Summary
On June 17, 2025, iTeos Therapeutics, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated in Delaware, is involved in the biological products sector and is headquartered in Watertown, Massachusetts.
Why It Matters
This filing signals that iTeos Therapeutics is convening a meeting or seeking shareholder approval for specific corporate actions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine procedural report regarding a vote of security holders and does not disclose any immediate financial distress or significant operational changes.
Key Numbers
- 001-39401 — SEC File Number (Identifies the company's filing history with the SEC.)
- 84-3365066 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- iTeos Therapeutics, Inc. (company) — Registrant
- June 17, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Watertown, Massachusetts (location) — Principal Executive Offices
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that such matters are being submitted.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 17, 2025.
What is the primary business of iTeos Therapeutics, Inc.?
The company is classified under Biological Products (No Diagnostic Substances) [2836].
Where are iTeos Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 321 Arsenal Street, Watertown, Massachusetts, 02472.
What is the SEC file number for iTeos Therapeutics, Inc.?
The SEC file number is 001-39401.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 17, 2025 regarding iTeos Therapeutics, Inc..